147 results
Page 4 of 8
8-K
EX-99.1
zckr ztvcj
17 Jun 21
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
7:35am
8-K
EX-99.1
5y6cvjop 3wkm
13 May 21
Synlogic Reports First Quarter Financial Results and Provides Business Update
6:46am
8-K
EX-99.2
hm327c43cv
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
8-K
EX-1.1
ddb96llujmofmqva wp5
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
8-K
EX-99.1
n7z8e cwf
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
8-K
EX-99.2
vi8v6jzy
14 Apr 21
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
12:00am
8-K
EX-99.1
4l58bk24dyk
14 Apr 21
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
12:00am
8-K
EX-99.1
kmzmnrsrdxw pwnum5
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.3
lvg74u7ly 2pea
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.2
7eonh80af0
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.1
7031j8jhe02 bd7bvy1p
24 Mar 21
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
4:59pm
8-K
EX-99.1
trgqbs6bg07mkcuw89
8 Mar 21
Synlogic Announces Promotion of Dr. Caroline Kurtz to Chief Development Officer and Strengthening of Leadership Team
7:25am
8-K
EX-99.1
xly1nl 404
10 Feb 21
Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors
9:04am
8-K
EX-99.1
1ee5gaq5io019hh0ya0
14 Dec 20
Results of Operations and Financial Condition
6:03am
8-K
EX-99.1
opr0s0uyjlz07jgwoeb
10 Dec 20
Synlogic Appoints Michael Heffernan to its Board of Directors
12:00am
8-K
EX-99.2
d41q jfgg
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am
8-K
EX-99.3
c3n6qyvhk23
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am